Pfizer Ltd

₹ 4,614 -2.38%

13 May - close price

About

Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also has various independent contract/ third party manufacturers based across the country and sells its products through independent distributors primarily in India.^[1]
It is the 3rd largest multinational pharmaceutical company in India.^[2]

Key Points

Parentage
The company is a subsidiary of Pfizer Inc. one of the world’s leading biopharma companies with a presence in over 125 countries. Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. ^[1] ^[2]

Website BSE NSE

Market Cap ₹ 21,092 Cr.
Current Price ₹ 4,614
High / Low ₹ 5,993 / 4,302
Stock P/E 27.8
Book Value ₹ 919
Dividend Yield 0.76 %
ROCE 24.2 %
ROE 18.0 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is almost debt free.
Company has been maintaining a healthy dividend payout of 58.3%

Cons

The company has delivered a poor sales growth of 2.39% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE 500 BSE Healthcare Nifty 500 BSE 250 SmallCap Index BSE 400 MidSmallCap Index Nifty MidSmallcap 400 Nifty Smallcap 250 Nifty 500 Multicap 50:25:25 Nifty Total Market Nifty MidSmall Healthcare Nifty Smallcap250 Quality 50 Nifty500 Equal Weight Nifty500 LargeMidSmall Equal-Cap Weighted BSE 1000 BSE 500 Dividend Leaders 50 Nifty500 Healthcare Nifty Smallcap 500

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
	573	531	575	540	547	563	589	538	592	603	642	645	629
	391	421	393	387	357	385	399	392	364	393	412	417	393
Operating Profit	182	111	183	153	189	177	189	146	228	210	230	228	236
OPM %	32%	21%	32%	28%	35%	32%	32%	27%	38%	35%	36%	35%	38%
	12	33	36	44	75	42	43	43	217	67	42	-20	50
Interest	3	3	3	3	7	2	2	2	3	3	2	2	2
Depreciation	26	16	15	18	14	15	15	15	16	14	14	14	15
Profit before tax	165	126	201	176	244	203	215	172	426	260	255	192	269
Tax %	21%	26%	26%	26%	27%	26%	26%	26%	22%	26%	26%	26%	26%
	130	94	149	130	179	151	158	128	331	192	189	142	200
EPS in Rs	28.34	20.44	32.56	28.41	39.10	32.94	34.61	27.89	72.34	41.91	41.32	31.00	43.68
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	1,853	2,012	1,966	1,969	2,082	2,152	2,239	2,611	2,425	2,193	2,281	2,520
	1,438	1,579	1,616	1,468	1,516	1,578	1,526	1,775	1,616	1,555	1,540	1,616
Operating Profit	414	433	350	501	566	574	712	836	809	638	742	904
OPM %	22%	22%	18%	25%	27%	27%	32%	32%	33%	29%	33%	36%
	44	97	232	114	167	183	81	63	134	185	344	139
Interest	2	1	2	1	2	11	15	11	13	15	8	9
Depreciation	250	58	63	66	71	103	109	115	106	62	61	58
Profit before tax	207	470	517	548	660	642	669	773	824	746	1,016	976
Tax %	66%	35%	35%	34%	35%	21%	26%	21%	24%	26%	24%	26%
	70	305	337	360	429	509	498	613	624	551	768	722
EPS in Rs	15.26	66.67	73.62	78.71	93.79	111.29	108.77	133.90	136.38	120.52	167.79	157.92
Dividend Payout %	82%	22%	27%	25%	24%	297%	32%	26%	29%	29%	98%	48%

Compounded Sales Growth
10 Years:	2%
5 Years:	2%
3 Years:	1%
TTM:	10%

Compounded Profit Growth
10 Years:	10%
5 Years:	9%
3 Years:	8%
TTM:	18%

Stock Price CAGR
10 Years:	10%
5 Years:	-3%
3 Years:	7%
1 Year:	7%

Return on Equity
10 Years:	17%
5 Years:	18%
3 Years:	17%
Last Year:	18%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	46	46	46	46	46	46	46	46	46	46	46	46
Reserves	1,927	2,118	2,373	2,637	2,966	3,350	2,347	2,819	3,162	3,550	4,172	4,157
	2	2	2	2	2	2	63	39	41	40	41	70
	638	722	840	1,004	926	1,007	810	997	752	593	653	649
Total Liabilities	2,614	2,888	3,261	3,690	3,940	4,405	3,266	3,901	4,001	4,229	4,911	4,922
	944	925	902	950	886	973	894	869	749	713	724	678
CWIP	13	3	15	1	0	1	3	1	8	0	8	20
Investments	43	37	0	0	0	0	0	0	0	0	0	0
	1,614	1,923	2,343	2,739	3,054	3,432	2,369	3,030	3,244	3,516	4,180	4,224
Total Assets	2,614	2,888	3,261	3,690	3,940	4,405	3,266	3,901	4,001	4,229	4,911	4,922

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	113	345	329	332	98	323	427	667	356	257	660	968
	68	-701	-250	-238	35	1,530	-469	-575	-36	54	-71	-562
	-1	-62	-83	-110	-110	-164	-1,571	-181	-346	-235	-205	-798
Net Cash Flow	181	-417	-3	-17	23	1,690	-1,613	-88	-26	75	383	-392
Free Cash Flow	93	398	394	262	125	343	410	654	292	291	783	944
CFO/OP	62%	120%	146%	105%	59%	93%	89%	107%	81%	64%	110%	105%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	32	26	20	29	30	29	18	20	23	31	31	26
Inventory Days	191	167	148	147	189	198	199	173	175	200	214	195
Days Payable	165	157	178	245	213	197	130	102	91	77	68	89
Cash Conversion Cycle	58	36	-10	-69	6	31	87	91	107	154	177	132
Working Capital Days	7	-9	-47	-57	-16	-8	3	-14	1	24	23	9
ROCE %	24%	22%	17%	21%	23%	20%	23%	29%	26%	22%	22%	24%

Insights

In beta

Mar 2015

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Prevenar 13 Market Share (Value)
%

xx.xx	xx.xx	xx.xx	xx.xx	xx.xx		xx.xx	xx.xx	xx.xx	xx.xx	xx.xx
x.xx		x.xx	x.xx	x.xx		x.xx	x.xx		x.xx	x.xx
xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx
xx					xx	xx	xx	xx	xx	xx
xx.xx				xx.xx	xx.xx		xx.xx			xx.xx
xxx,xxx						xxx,xxx	xxx,xxx		xxx,xxx	xxx,xxx
x,xxx					xx,xxx	x,xxx	x,xxx
xx						xx	x	x
xx.xx	xx.xx				xx.xx
	x.xx	x.xx

Please log in to see hidden values.

Goa Plant Annual Production Volume (Tablets)
Billion Units

Becosules Category Market Share
%

Pacitane Market Share
%

Eliquis Market Share (Represented Market)
%

Healthcare Professional (HCP) Outreach
Numbers

Number of Stockists
Numbers

Operational Productivity Growth (Goa Plant)
%

Share of Global Product Portfolio in Revenue
%

R&D Expenditure (Percentage of Turnover)
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

2 Recently

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%
	2.81%	2.82%	3.03%	3.32%	3.22%	3.54%	2.74%	2.18%	2.40%	2.60%	2.71%	2.81%
	14.89%	15.00%	15.15%	15.32%	15.83%	16.03%	16.80%	17.10%	17.23%	17.11%	17.05%	16.89%
	18.37%	18.24%	17.87%	17.42%	17.00%	16.50%	16.54%	16.79%	16.45%	16.37%	16.32%	16.36%
No. of Shareholders	1,15,988	1,16,948	1,12,456	1,09,214	1,06,098	98,824	1,05,015	1,08,261	1,03,222	1,03,480	1,00,933	99,545

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%
	2.89%	3.01%	4.20%	3.69%	1.89%	2.20%	2.80%	3.32%	2.18%	2.81%
	10.53%	11.91%	11.98%	12.66%	14.63%	15.06%	14.89%	15.32%	17.10%	16.89%
	22.66%	21.16%	19.90%	19.73%	19.55%	18.82%	18.38%	17.42%	16.79%	16.36%
No. of Shareholders	85,570	72,919	76,717	82,750	1,45,980	1,25,287	1,17,194	1,09,214	1,08,261	99,545

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

Concalls

Aug 2020
Transcript
PPT
May 2017
Transcript
PPT
Feb 2017
Transcript
PPT
Nov 2016
Transcript
PPT
Aug 2016
Transcript
PPT
May 2016
Transcript
PPT
Feb 2016
Transcript
PPT